Navigation Links
Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
Date:2/29/2012

CARLSBAD, Calif., Feb. 29, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced a revision to the Company's earnings release dated February 7, 2012.  Subsequent to the release but before the Company issued its financial statements for the fiscal year ended December 31, 2011, a court entered judgment against the Company on a case in litigation.  The case, depending on the final outcome, could require the Company to pay additional damages of up to three times the judgment plus plaintiff's attorney's fees. The Company does not expect this verdict to have a material impact on its business going forward.  Although the Company is considering all its options in view of the judgment, including filing various post-trial motions and an appeal, the Company has recorded a charge of approximately $56 million related to the lawsuit and unpaid royalties in the fourth quarter of fiscal 2011. As a result, the Company's previously reported fourth quarter and full year 2011 GAAP diluted earnings per share will decrease $0.18 per share from $0.69 and $2.23 per share to $0.51 and $2.05 per share, respectively.  Non-GAAP diluted earnings per share will decrease $0.01 per share from $1.06 to $1.05 for the fourth quarter ended December 31, 2011 and $0.02 per share from $3.73 to $3.71 for the year ended December 31, 2011.  The Company has provided revised financial statements and a reconciliation of the Consolidated Statements of Operations provided on February 7, 2012 to the revised Consolidated Statements of Operations.  

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

The full updated press release follows:Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results

  • Fourth quarter revenue increased 4 percent to $970 m
    '/>"/>

  • SOURCE Life Technologies Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

    Related biology technology :

    1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    2. RainDance Technologies Appoints Olex Vice President, System Development
    3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
    4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
    5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
    6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
    7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
    8. Anthill Technologies Announces Agreement With Zafgen
    9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
    10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... 30, 2014  Replikins Ltd. today released new data ... virus. Before the current outbreaks, the mean Ebola Reston ... acids) between 1995 and 2002 was 1.1; the mean ... and sixteen-fold in 2013, thus predicting the current outbreaks ... has been shown to be able to predict outbreaks ...
    (Date:7/30/2014)... , July 30, 2014   Wyle ... Fully Integrated Lifecycle Mission Support Services (FILMSS) contract ... (NASA). Under the terms of the contract, Wyle ... at Moffett Field, Calif. In particular, Wyle will ... flight development projects on the International Space Station ...
    (Date:7/30/2014)... Vycom announces the addition of Thermax PVC ... Factory Mutual (FM) 4910 fire propagation and smoke generation ... process tools, fume hoods, furniture and cabinetry. These criteria ... wafers used in electronic chip manufacturing. , ... excellent workability and superior aesthetics. It is available in ...
    (Date:7/30/2014)... July 30, 2014 Researchers often use ... biology, but such devices can do much more ... As such, researchers have looked to patterned assemblies ... metabolic engineering to characterize – and potentially ... devices are envisioned to recreate animal and human ...
    Breaking Biology Technology:Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
    ... LEUVEN, Belgium and LUND, Sweden, September 7 ... Anticoagulant Into Phase,II Clinical Development ThromboGenics NV ... disease, and co-development partner, BioInvent,International (Nordic Exchange: BINV), ... initial follow-up of all volunteers,in the first Phase ...
    ... 6 Globally, approximately 418 billion,people are currently ... costs of hepatitis in the 21st century cannot ... a,new report by Kalorama Information. Paradoxically, despite ... necessary steps to contain hepatitis. Yet the incidence ...
    ... VRUS ) and Roche (OTC: RHHBY) announced ... the treatment of chronic hepatitis C,virus (HCV) will ... Hepatitis C,Virus and Related Viruses being held from ... of PSI-6130, is an oral cytidine nucleoside,analog polymerase ...
    Cached Biology Technology:ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 2ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 3ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 4ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 5Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health 2Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 2Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 3Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 4Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses 5
    (Date:7/31/2014)... can affect animal movement and communication, with unknown ecological ... and the cole Pratique des Hautes tudes (EPHE) CRIOBE ... development and increases larval mortality in sea hares. , ... used in this study) usually hatch from their ... alga but this study, conducted in a coral reef ...
    (Date:7/31/2014)... new meta-analyses involving tree nuts (almonds, Brazil nuts, cashews, ... recently published in the online publications, British Medical ... ONE (ii). The BMJ Open article ... syndrome (MetS) criteria and showed that tree nut consumption ... blood glucose. The PLOS ONE article focused ...
    (Date:7/30/2014)... paving the way for a breakthrough that may ... exposed to poisonous chemicalsparticularly those in pesticides and ... current issue of the journal ChemBioChem ... compounds commonly used in pesticides and warfare agents. ... of Engineering Associate Professor of Chemical and Biological ...
    Breaking Biology News(10 mins):Boat noise impacts development and survival of sea hares 2New international tree nut council study looks at nuts, diabetes and metabolic syndrome 2Engineering a protein to prevent brain damage from toxic agents 2
    ... Washington, D.C. (September 14, 2010) -- Piezoelectric materials ... electrical field. And vice-versa, they contract or expand when ... from the Greek word meaning to squeeze or press, ... was discovered in several crystals in 1880. But in ...
    ... Charlotte, North Carolina is a rapidly growing city. Charlotte ... that as a contradiction. , In Charlotte, there are ... shadow of the towers of the nation,s second largest ... undeveloped land within the city,s boundaries. Social scientists find ...
    ... EVANSTON, Ill. --- It seems the old nature versus ... study of men in the Philippines makes a strong case ... that rapid weight gain in the first six months of ... experienced rapid growth as babies -- an indication that they ...
    Cached Biology News:Lead-free piezoelectric materials of the future 2Interdisciplinary research looks at Charlotte's green mystery 2Interdisciplinary research looks at Charlotte's green mystery 3Interdisciplinary research looks at Charlotte's green mystery 4Interdisciplinary research looks at Charlotte's green mystery 5Interdisciplinary research looks at Charlotte's green mystery 6Male maturity shaped by early nutrition 2Male maturity shaped by early nutrition 3
    Functionally tested for consistent G-banding of chromosomes....
    ... BacVector Insect Cell Medium is optimized ... Ea4 Insect Cells. In this protein-free medium, ... 1 * 107 cells/ml with viabilities above ... plaque assays, where color from X-gluc staining ...
    ... Grace's Insect Medium is formuatled for ... including Sf9 and Sf21 cells. Grace's ... transfectioin because it does not contain ... interfere with transfection. Grace's Insect Medium, ...
    TNM-FH Insect Medium 1 liter...
    Biology Products: